{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,4]],"date-time":"2026-11-04T03:39:07Z","timestamp":1793763547528,"version":"4.6.1"},"reference-count":49,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,2,1]],"date-time":"2024-02-01T00:00:00Z","timestamp":1706745600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,2,1]],"date-time":"2024-02-01T00:00:00Z","timestamp":1706745600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,1,15]],"date-time":"2025-01-15T00:00:00Z","timestamp":1736899200000},"content-version":"am","delay-in-days":349,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,2,1]],"date-time":"2024-02-01T00:00:00Z","timestamp":1706745600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,2,1]],"date-time":"2024-02-01T00:00:00Z","timestamp":1706745600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,2,1]],"date-time":"2024-02-01T00:00:00Z","timestamp":1706745600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,2,1]],"date-time":"2024-02-01T00:00:00Z","timestamp":1706745600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,2,1]],"date-time":"2024-02-01T00:00:00Z","timestamp":1706745600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100001807","name":"Funda\u00e7\u00e3o de Amparo \u00e0 Pesquisa do Estado de S\u00e3o Paulo","doi-asserted-by":"publisher","award":["2022\/02175-1"],"award-info":[{"award-number":["2022\/02175-1"]}],"id":[{"id":"10.13039\/501100001807","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100005639","name":"Universidade de S\u00e3o Paulo","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100005639","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000066","name":"National Institute of Environmental Health Sciences","doi-asserted-by":"publisher","award":["R01 ES09649"],"award-info":[{"award-number":["R01 ES09649"]}],"id":[{"id":"10.13039\/100000066","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100010937","name":"St. John's University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100010937","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Toxicology"],"published-print":{"date-parts":[[2024,2]]},"DOI":"10.1016\/j.tox.2023.153719","type":"journal-article","created":{"date-parts":[[2024,1,3]],"date-time":"2024-01-03T18:54:51Z","timestamp":1704308091000},"page":"153719","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":25,"special_numbering":"C","title":["Distinct bile acid alterations in response to a single administration of PFOA and PFDA in mice"],"prefix":"10.1016","volume":"502","author":[{"given":"Xiaoxiao","family":"Yu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Youcai","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bruno","family":"Cogliati","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Curtis D.","family":"Klaassen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sanaya","family":"Kumar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xingguo","family":"Cheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pengli","family":"Bu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"42","key":"10.1016\/j.tox.2023.153719_bib1","doi-asserted-by":"crossref","first-page":"39088","DOI":"10.1074\/jbc.M107073200","article-title":"Peroxisome proliferator-activated receptor-alpha regulates lipid homeostasis, but is not associated with obesity: studies with congenic mouse lines","volume":"276","author":"Akiyama","year":"2001","journal-title":"J. Biol. Chem."},{"issue":"2","key":"10.1016\/j.tox.2023.153719_bib2","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1016\/j.jchromb.2008.08.018","article-title":"Quantitative-profiling of bile acids and their conjugates in mouse liver, bile, plasma, and urine using LC-MS\/MS","volume":"873","author":"Alnouti","year":"2008","journal-title":"J. Chromatogr. B Anal. Technol. Biomed. Life Sci."},{"issue":"Suppl. 1: s3-105.","key":"10.1016\/j.tox.2023.153719_bib3","doi-asserted-by":"crossref","first-page":"s53","DOI":"10.5604\/01.3001.0010.5497","article-title":"Bile acids in cholestasis and its treatment","volume":"16","author":"Arab","year":"2017","journal-title":"Ann. Hepatol."},{"issue":"3","key":"10.1016\/j.tox.2023.153719_bib4","doi-asserted-by":"crossref","first-page":"1035","DOI":"10.1002\/j.2040-4603.2013.tb00519.x","article-title":"Bile formation and secretion","volume":"3","author":"Boyer","year":"2013","journal-title":"Compr. Physiol."},{"key":"10.1016\/j.tox.2023.153719_bib5","doi-asserted-by":"crossref","first-page":"1863","DOI":"10.1124\/dmd.106.010520","article-title":"Regulation of mRNA expression of xenobiotic transporters by the pregnane-X receptor (PXR) in mouse liver, kidney, and intestine","volume":"34","author":"Cheng","year":"2006","journal-title":"Drug Metab. Dispos."},{"issue":"1","key":"10.1016\/j.tox.2023.153719_bib6","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1093\/toxsci\/kfn161","article-title":"Critical role of PPAR-alpha in perfluorooctanoic acid- and perfluorodecanoic acid-induced downregulation of Oatp uptake transporters in mouse livers","volume":"106","author":"Cheng","year":"2008","journal-title":"Toxicol. Sci."},{"issue":"1","key":"10.1016\/j.tox.2023.153719_bib7","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1093\/toxsci\/kfn147","article-title":"Perfluorocarboxylic acids induce cytochrome P450 enzymes in mouse liver through activation of PPAR-alpha and CAR transcription factors","volume":"106","author":"Cheng","year":"2008","journal-title":"Toxicol. Sci."},{"issue":"9","key":"10.1016\/j.tox.2023.153719_bib8","doi-asserted-by":"crossref","first-page":"1276","DOI":"10.1124\/dmd.105.003988","article-title":"Regulation of mouse organic anion-transporting polypeptides (Oatps) in liver by prototypical microsomal enzyme inducers that activate distinct transcription factor pathways","volume":"33","author":"Cheng","year":"2005","journal-title":"Drug Metab. Dispos."},{"issue":"11","key":"10.1016\/j.tox.2023.153719_bib9","doi-asserted-by":"crossref","first-page":"1665","DOI":"10.1016\/j.bcp.2007.08.014","article-title":"Regulation of hepatic bile acid transporters Ntcp and Bsep expression","volume":"74","author":"Cheng","year":"2007","journal-title":"Biochem Pharm."},{"key":"10.1016\/j.tox.2023.153719_bib10","doi-asserted-by":"crossref","unstructured":"Choudhuri S., Klaassen C.D., 2021. MOLECULAR REGULATION OF BILE ACID HOMEOSTASIS. Drug Metabolism and Disposition:DMD-MR-2021\u2013000643 doi:10.1124\/dmd.121.000643.","DOI":"10.1124\/dmd.121.000643"},{"issue":"10","key":"10.1016\/j.tox.2023.153719_bib11","doi-asserted-by":"crossref","first-page":"2020","DOI":"10.1161\/01.ATV.0000178994.21828.a7","article-title":"The Farnesoid X receptor: a molecular link between bile acid and lipid and glucose metabolism","volume":"25","author":"Claudel","year":"2005","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"issue":"4","key":"10.1016\/j.tox.2023.153719_bib12","doi-asserted-by":"crossref","first-page":"46001","DOI":"10.1289\/EHP10092","article-title":"Exposure to per- and polyfluoroalkyl substances and markers of liver injury: a systematic review and meta-analysis","volume":"130","author":"Costello","year":"2022","journal-title":"Environ. Health Perspect."},{"issue":"1","key":"10.1016\/j.tox.2023.153719_bib13","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1002\/hep.23984","article-title":"Organic anion-transporting polypeptide 1b2 (Oatp1b2) is important for the hepatic uptake of unconjugated bile acids: studies in Oatp1b2-null mice","volume":"53","author":"Csanaky","year":"2011","journal-title":"Hepatology"},{"issue":"3","key":"10.1016\/j.tox.2023.153719_bib14","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1002\/etc.4890","article-title":"Per- and polyfluoroalkyl substance toxicity and human health review: current state of knowledge and strategies for informing future research","volume":"40","author":"Fenton","year":"2021","journal-title":"Environ. Toxicol. Chem."},{"issue":"1","key":"10.1016\/j.tox.2023.153719_bib15","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1093\/toxsci\/kfab068","article-title":"Species differences between mouse and human PPARalpha in modulating the hepatocarcinogenic effects of perinatal exposure to a high-affinity human PPARalpha agonist in mice","volume":"183","author":"Foreman","year":"2021","journal-title":"Toxicol. Sci."},{"issue":"3","key":"10.1016\/j.tox.2023.153719_bib16","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1016\/j.ijheh.2008.04.007","article-title":"Perfluorinated compounds--exposure assessment for the general population in Western countries","volume":"212","author":"Fromme","year":"2009","journal-title":"Int J. Hyg. Environ. Health"},{"issue":"8","key":"10.1016\/j.tox.2023.153719_bib17","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1002\/j.1552-4604.1987.tb03063.x","article-title":"Biliary excretion","volume":"27","author":"Gregus","year":"1987","journal-title":"J. Clin. Pharm."},{"key":"10.1016\/j.tox.2023.153719_bib18","doi-asserted-by":"crossref","first-page":"45062","DOI":"10.1074\/jbc.M307145200","article-title":"Complementary roles of farnesoid X receptor, pregnane X receptor, and constitutive androstane receptor in protection against bile acid toxicity","volume":"278","author":"Guo","year":"2003","journal-title":"J. Biol. Chem."},{"issue":"5","key":"10.1016\/j.tox.2023.153719_bib19","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1007\/s00424-003-1168-y","article-title":"Organic anion transporting polypeptides of the OATP\/ SLC21 family: phylogenetic classification as OATP\/ SLCO superfamily, new nomenclature and molecular\/functional properties","volume":"447","author":"Hagenbuch","year":"2004","journal-title":"Pflug. Arch."},{"issue":"1","key":"10.1016\/j.tox.2023.153719_bib20","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1080\/10915810252825975","article-title":"Xenobiotic transporters: another protective mechanism for chemicals","volume":"21","author":"Klaassen","year":"2002","journal-title":"Int J. Toxicol."},{"issue":"1","key":"10.1016\/j.tox.2023.153719_bib21","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1124\/pr.109.002014","article-title":"Xenobiotic, bile acid, and cholesterol transporters: function and regulation","volume":"62","author":"Klaassen","year":"2010","journal-title":"Pharm. Rev."},{"key":"10.1016\/j.tox.2023.153719_bib22","first-page":"345","article-title":"The PPARs and PXRs: nuclear xenobiotic receptors that define novel hormone signaling pathways","volume":"54","author":"Kliewer","year":"1999","journal-title":"Recent Prog. Horm. Res"},{"issue":"6","key":"10.1016\/j.tox.2023.153719_bib23","doi-asserted-by":"crossref","first-page":"3012","DOI":"10.1128\/MCB.15.6.3012","article-title":"Targeted disruption of the alpha isoform of the peroxisome proliferator-activated receptor gene in mice results in abolishment of the pleiotropic effects of peroxisome proliferators","volume":"15","author":"Lee","year":"1995","journal-title":"Mol. Cell Biol."},{"issue":"5","key":"10.1016\/j.tox.2023.153719_bib24","doi-asserted-by":"crossref","first-page":"895","DOI":"10.1016\/j.bbadis.2018.05.011","article-title":"Animal models to study bile acid metabolism","volume":"1865","author":"Li","year":"2019","journal-title":"Biochim Biophys. Acta Mol. Basis Dis."},{"key":"10.1016\/j.tox.2023.153719_bib25","doi-asserted-by":"crossref","DOI":"10.1155\/2009\/501739","article-title":"Regulation of bile acid and cholesterol metabolism by PPARs","volume":"2009","author":"Li","year":"2009","journal-title":"PPAR Res"},{"issue":"4","key":"10.1016\/j.tox.2023.153719_bib26","doi-asserted-by":"crossref","first-page":"948","DOI":"10.1124\/pr.113.008201","article-title":"Bile acid signaling in metabolic disease and drug therapy","volume":"66","author":"Li","year":"2014","journal-title":"Pharm. Rev."},{"key":"10.1016\/j.tox.2023.153719_bib27","doi-asserted-by":"crossref","first-page":"956","DOI":"10.1124\/dmd.105.003798","article-title":"Induction of the multidrug resistance-associated protein family of transporters by chemical activators of receptor-mediated pathways in mouse liver","volume":"33","author":"Maher","year":"2005","journal-title":"Drug Metab. Dispos."},{"issue":"2","key":"10.1016\/j.tox.2023.153719_bib28","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1093\/toxsci\/kfn177","article-title":"Nrf2- and PPAR alpha-mediated regulation of hepatic Mrp transporters after exposure to perfluorooctanoic acid and perfluorodecanoic acid","volume":"106","author":"Maher","year":"2008","journal-title":"Toxicol. Sci."},{"issue":"4","key":"10.1016\/j.tox.2023.153719_bib29","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1016\/S0022-2275(20)32398-1","article-title":"Peroxisome proliferator-activated receptor alpha (PPARalpha) and agonist inhibit cholesterol 7alpha-hydroxylase gene (CYP7A1) transcription","volume":"41","author":"Marrapodi","year":"2000","journal-title":"J. Lipid Res"},{"issue":"5","key":"10.1016\/j.tox.2023.153719_bib30","doi-asserted-by":"crossref","first-page":"1074","DOI":"10.1093\/carcin\/bgi329","article-title":"Differential susceptibility of mice humanized for peroxisome proliferator-activated receptor alpha to Wy-14,643-induced liver tumorigenesis","volume":"27","author":"Morimura","year":"2006","journal-title":"Carcinogenesis"},{"issue":"3","key":"10.1016\/j.tox.2023.153719_bib31","doi-asserted-by":"crossref","first-page":"720","DOI":"10.1016\/j.jhep.2014.10.039","article-title":"Molecular mechanism of PPARalpha action and its impact on lipid metabolism, inflammation and fibrosis in non-alcoholic fatty liver disease","volume":"62","author":"Pawlak","year":"2015","journal-title":"J. Hepatol."},{"issue":"6","key":"10.1016\/j.tox.2023.153719_bib32","doi-asserted-by":"crossref","first-page":"437","DOI":"10.2217\/bmm-2020-0691","article-title":"Biomarkers of cholestasis","volume":"15","author":"Pieters","year":"2021","journal-title":"Biomark. Med"},{"issue":"11","key":"10.1016\/j.tox.2023.153719_bib33","doi-asserted-by":"crossref","first-page":"1840","DOI":"10.1161\/hq1101.098228","article-title":"Fibrates suppress bile acid synthesis via peroxisome proliferator-activated receptor-alpha-mediated downregulation of cholesterol 7alpha-hydroxylase and sterol 27-hydroxylase expression","volume":"21","author":"Post","year":"2001","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"10.1016\/j.tox.2023.153719_bib34","doi-asserted-by":"crossref","first-page":"289","DOI":"10.2174\/1568008054863781","article-title":"Role of FXR in regulating bile acid homeostasis and relevance for human diseases","volume":"5","author":"Rizzo","year":"2005","journal-title":"Curr. Drug Targets Immune Endocr. Metab. Disord."},{"issue":"4","key":"10.1016\/j.tox.2023.153719_bib35","doi-asserted-by":"crossref","first-page":"221","DOI":"10.3390\/livers1040017","article-title":"Perfluoroalkyl carboxylic acids interact with the human bile acid transporter NTCP","volume":"1","author":"Ruggiero","year":"2021","journal-title":"Livers"},{"issue":"42","key":"10.1016\/j.tox.2023.153719_bib36","doi-asserted-by":"crossref","first-page":"39411","DOI":"10.1074\/jbc.M106340200","article-title":"Disrupted bile acid homeostasis reveals an unexpected interaction among nuclear hormone receptors, transporters, and cytochrome P450","volume":"276","author":"Schuetz","year":"2001","journal-title":"J. Biol. Chem."},{"issue":"2","key":"10.1016\/j.tox.2023.153719_bib37","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1124\/jpet.107.135822","article-title":"NF-E2-related factor 2 inhibits lipid accumulation and oxidative stress in mice fed a high-fat diet","volume":"325","author":"Tanaka","year":"2008","journal-title":"J. Pharm. Exp. Ther."},{"issue":"8","key":"10.1016\/j.tox.2023.153719_bib38","doi-asserted-by":"crossref","first-page":"678","DOI":"10.1038\/nrd2619","article-title":"Targeting bile-acid signalling for metabolic diseases","volume":"7","author":"Thomas","year":"2008","journal-title":"Nat. Rev. Drug Discov."},{"issue":"3","key":"10.1016\/j.tox.2023.153719_bib39","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1016\/j.steroids.2006.12.006","article-title":"CAR and PXR: the xenobiotic-sensing receptors.","volume":"72","author":"Timsit","year":"2007","journal-title":"Steroids"},{"issue":"1","key":"10.1016\/j.tox.2023.153719_bib40","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1124\/mol.61.1.1","article-title":"Diverse roles of the nuclear orphan receptor CAR in regulating hepatic genes in response to phenobarbital","volume":"61","author":"Ueda","year":"2002","journal-title":"Mol. Pharm."},{"issue":"5","key":"10.1016\/j.tox.2023.153719_bib41","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1016\/S1097-2765(00)80348-2","article-title":"Endogenous bile acids are ligands for the nuclear receptor FXR\/BAR","volume":"3","author":"Wang","year":"1999","journal-title":"Mol. Cell"},{"issue":"2","key":"10.1016\/j.tox.2023.153719_bib42","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1093\/toxsci\/kfp275","article-title":"Roles of rat renal organic anion transporters in transporting perfluorinated carboxylates with different chain lengths","volume":"113","author":"Weaver","year":"2010","journal-title":"Toxicol. Sci."},{"issue":"1","key":"10.1016\/j.tox.2023.153719_bib43","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1093\/toxsci\/kfm206","article-title":"The PPAR alpha-humanized mouse: a model to investigate species differences in liver toxicity mediated by PPAR alpha","volume":"101","author":"Yang","year":"2008","journal-title":"Toxicol. Sci."},{"issue":"2","key":"10.1016\/j.tox.2023.153719_bib44","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1093\/toxsci\/kfx191","article-title":"Editor's highlight: clofibrate decreases bile acids in livers of male mice by increasing biliary bile acid excretion in a PPARalpha-dependent manner","volume":"160","author":"Zhang","year":"2017","journal-title":"Toxicol. Sci."},{"key":"10.1016\/j.tox.2023.153719_bib45","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1016\/j.taap.2017.11.014","article-title":"Activation of PPARalpha decreases bile acids in livers of female mice while maintaining bile flow and biliary bile acid excretion","volume":"338","author":"Zhang","year":"2018","journal-title":"Toxicol. Appl. Pharm."},{"issue":"1","key":"10.1016\/j.tox.2023.153719_bib46","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1093\/toxsci\/kfx237","article-title":"Alteration of bile acid and cholesterol biosynthesis and transport by perfluorononanoic acid (PFNA) in mice","volume":"162","author":"Zhang","year":"2018","journal-title":"Toxicol. Sci."},{"issue":"2","key":"10.1016\/j.tox.2023.153719_bib47","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1093\/toxsci\/kfv102","article-title":"Na+\/taurocholate cotransporting polypeptide and apical sodium-dependent bile acid transporter are involved in the disposition of perfluoroalkyl sulfonates in humans and rats","volume":"146","author":"Zhao","year":"2015","journal-title":"Toxicol. Sci."},{"key":"10.1016\/j.tox.2023.153719_bib48","article-title":"Organic anion transporting polypeptides contribute to the disposition of perfluoroalkyl acids in humans and rats","author":"Zhao","year":"2017","journal-title":"Toxicol. Sci. 156(1):84-95"},{"issue":"1","key":"10.1016\/j.tox.2023.153719_bib49","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.cld.2007.11.010","article-title":"Mechanisms of cholestasis","volume":"12","author":"Zollner","year":"2008","journal-title":"Clin. Liver Dis."}],"container-title":["Toxicology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0300483X23003062?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0300483X23003062?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,3]],"date-time":"2025-10-03T23:55:29Z","timestamp":1759535729000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0300483X23003062"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,2]]},"references-count":49,"alternative-id":["S0300483X23003062"],"URL":"https:\/\/doi.org\/10.1016\/j.tox.2023.153719","relation":{},"ISSN":["0300-483X"],"issn-type":[{"value":"0300-483X","type":"print"}],"subject":[],"published":{"date-parts":[[2024,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Distinct bile acid alterations in response to a single administration of PFOA and PFDA in mice","name":"articletitle","label":"Article Title"},{"value":"Toxicology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.tox.2023.153719","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"153719"}}